CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
CASH FLOWS - OPERATING ACTIVITIES
Net income (loss)	$ 3,748	$ 661	$ (4,022)
Adjustments to reconcile net loss to net cash used in operating activities:
Accrued interest on loans	2,315	1,485	2,148
Loan forgiveness gain	(4,381)	(2,312)	0
Depreciation and amortization	3,826	3,386	2,980
Stock-based compensation to employees	854	402	243
Stock-based compensation issued pursuant to settlement agreements	0	403	0
Decrease in deferred tax	(2,010)	(418)	0
Change in Fair value of derivatives & warrants liability	699	(798)	(2,313)
Credit Losses	1,853	1,540	1,457
Inventory write-downs	334	130	180
Decrease in accounts receivables, net	(11,432)	(3,064)	(4,135)
Decrease (increase) in other current assets	(1,666)	(597)	670
Decrease (increase) in inventories, net	(22)	(148)	728
Increase (decrease) in accounts payables	273	(1,005)	616
Increase (decrease) in employees and payroll accruals	467	150	(325)
Increase (decrease) in accrued severance pay	0	0	(41)
Lease liabilities	(606)	(671)	(604)
Increase (decrease) in accrued expenses and other liabilities, related parties & deferred revenues	258	(438)	51
Net cash used in operating activities	(5,490)	(1,294)	(2,367)
CASH FLOWS - INVESTING ACTIVITIES
Purchase of property and equipment	(880)	(1,598)	(1,714)
Capitalization of software development costs	(2,196)	(1,751)	(1,652)
Investment in bank deposits	2,366	0	0
Net cash used in investing activities	(5,442)	(3,349)	(3,366)
CASH FLOWS - FINANCING ACTIVITIES
Related parties	0	(100)	(68)
Proceeds from loans and credit	671	0	0
Proceeds from exercise of options and warrants, net	11,059	0	1,819
Proceed from Shares and warrants issuance, net	5,550	2,704	5,054
Net cash provided by financing activities	17,280	2,604	6,805
Increase (decrease) in cash, cash equivalents, and restricted cash	6,348	(2,039)	1,072
Cash, cash equivalents, and restricted cash - beginning of year	3,538	5,577	4,505
Cash, cash equivalents, and restricted cash - end of year	9,886	3,538	5,577
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
Cash paid for taxes	0	0	0
Cash paid for interest, net	0	0	0
NON-CASH TRANSACTIONS:
Conversion of loans and warrant into ordinary shares	$ 14,847	$ 3,747	$ 2,251

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2025	Dec. 31, 2024
CURRENT ASSETS
Cash and cash equivalents	$ 9,829	$ 3,150
Bank Deposit	2,366	0
Restricted bank deposit	57	388
Accounts receivable, net of allowance for doubtful accounts of $8,661 and $6,543 as of December 31, 2025 and 2024, respectively	15,045	12,767
Other current assets	2,566	2,061
Inventories, net	2,209	2,521
Patents held for sale	5,283	5,283
TOTAL CURRENT ASSETS	37,355	26,170
LONG-TERM ASSETS
Long term trade receivables net of credit losses allowance of $6,816 and 7,188	9,614	2,213
Property and equipment, net	3,023	3,261
Intangible assets, net	5,791	5,638
Goodwill	7,026	7,026
Other long-term assets	5,570	1,616
TOTAL LONG-TERM ASSETS	31,024	19,754
TOTAL ASSETS	68,379	45,924
CURRENT LIABILITIES
Accounts payable	1,151	878
Employees and payroll accruals	1,632	1,165
Related parties	0	0
Short- term loans	359	423
Accrued expenses and other liabilities	345	470
Short- term operating lease liabilities	425	445
Deferred revenues	778	366
TOTAL CURRENT LIABILITIES	4,690	3,747
LONG-TERM LIABILITIES
Long-term loans	18,713	29,748
Long- term operating lease liabilities	1,082	118
Other long-term liabilities	382	614
TOTAL LONG TERM LIABILITIES	20,177	30,480
TOTAL LIABILITIES	24,867	34,227
Commitments and contingent liabilities
SHAREHOLDERS' EQUITY
Ordinary shares, NIS 50 par value - authorized 5,000,000 shares, 5,369,367 and 2,172,855 shares issued and outstanding on December 31, 2025 and 2024, respectively	74,823	29,238
Additional paid-in capital	71,228	88,746
Accumulated deficit	(102,539)	(106,287)
Total shareholders' equity	43,512	11,697
Total liabilities and shareholders' equity	$ 68,379	$ 45,924